Please assess the completion status of the following clinical trial:

Trial Title: Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 18-90 years old~* suffers from dysphagia caused by an iatrogenic esophageal stricture~* the stricture is amenable for endoscopic dilation~* the patient has undergone at least 1 previous endoscopic dilation for the same stricture~* signed the ICF~Exclusion Criteria:~* the patient is not fluent in Dutch

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- local collagenase (Type: EXPERIMENTAL): Patients receiving local injection of collagenase (0.9 mg XiapexR) into the esophageals stricture

Based on this trial design, predict the completion outcome and termination type (if applicable).